by Infusion Ventures | Jul 30, 2020 | Company News, Infusion Nursing
Our team at Infusion Ventures is ready and capable of managing your home infusion therapy needs. With years of experience and the rigorous oversight of the Joint Commission, Infusion Ventures nurses use their critical care expertise not simply to administer specialty...
by Infusion Ventures | Jul 24, 2020 | Company News, Infusion Nursing
We are steadfast in being your child’s advocate for better health. Infusion Ventures administers infused medications to children including Hemophilia treatments, Enzyme Replacement Therapy and Immune Deficiency Treatments. Our nurses are trained and experienced...
by Infusion Ventures | Jul 20, 2020 | Company News, Infusion Nursing
Our experienced team of specialists will administer pharmaceutical infusion products for conditions such as hemophilia, Von Willebrands, IVIG, immune deficiencies, Gauchers, and HAE including: Advate Adynovate Aldurazyme Aralast Benefix Berinert Carimune ...
by Infusion Ventures | Jul 14, 2020 | Company News, Featured News
To the Infusion Ventures Community, Infusion Ventures remains steadfast in our commitment during the ongoing Coronavirus (COVID-19) pandemic and we are committed to being responsive to your infusion nursing needs. At this time, we continue to infuse our patients using...
by Infusion Ventures | Jul 8, 2020 | Company News, Featured News, Infusion Nursing
It’s in our DNA. Infusion Ventures began in 1993 specializing in the youngest patients. Today our company carries a large caseload of pediatric patients throughout New England. Our nurses are trained and experienced in infusions for even the youngest patients. Whether...
by Infusion Ventures | Jul 1, 2020 | Featured News, Infusion Nursing
Source Article: BioMarin’s Gene Therapy for Hemophilia A Continues to Prevent…